{"prompt": "['Protocol 036 (Nishijima, Kuppermann)', 'Page 19 of 74', 'INR/PT', 'Baseline Clinical Information', 'Examples of data elements:', 'GCS score (or Pediatric GCS score for those younger than 2 years-old)', 'Pupillary assessment', 'Vital signs', 'Presence of and types of traumatic brain injuries, abdominal injuries, thoracic', 'injuries, pelvic injuries, and orthopedic injuries', '3.3.1 Biomarker testing', 'We will collect blood samples for TEG and other biomarker tests prior to the start of study', 'drug infusion (baseline) and throughout the infusion. The results of the biomarker testing', 'will be used for research purposes only and not be available to clinicians. The amount of', 'blood drawn at each blood draw will be no more than 5-10 mls, or approximately one', 'to two teaspoons of blood per blood draw. This is well below the maximum allowable', 'volume (ml) of blood drawn for research purposes in children (5% of total blood volume).', 'Thromboelastography (TEG) testing Fibrinolysis is evaluated based on the percentage', 'of clot lysis at 30 minutes post-maximum clot strength (LY-30) (Figure 2). The TEG', 'testing will also provide information on coagulation factor function (clot time [r-value] and', 'rate [k-time and alpha-angle]), and platelet function (maximum clot strength [maximum', 'amplitude]). The TEG testing will be completed as soon as possible after enrollment into', 'the study by the trained site-specific staff. All sites have verified TEG testing availability', 'and processing time.', 'Although no studies have demonstrated an association between TEG directed man-', 'agement in injured patients and improved patient outcomes, TEG testing is emerging as', 'an efficient method for the rapid diagnosis of post-traumatic coagulopathy. It is widely', 'used in the operating room to direct transfusion protocols and many authors feel that it', 'may have a similar role in the trauma setting. 35-37 Hyperfibrinolysis defined as a LY30', 'of 3% is an independent predictor of mortality (odds ratio 6.2, 95% CI 2.47 to 16.27)', 'in severely injured pediatric trauma patients. 16 This increase in mortality with LY30', 'threshold of 3% is consistent with similar studies of adult trauma patients. 38, 39', 'This', 'same pediatric trauma study also found hyperfibrinolysis occurred more frequently in', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']['Page 20 of 74', 'Protocol 036 (Nishijima, Kuppermann)', 'Consent', 'Randomization/ Start of study drug', '24 h from start of drug', 'End of bolus', 'Completion of infusion', 'Blood draw 1 for', 'TXA level', 'TXA level', 'Blood draw 2 for', 'TXA level', 'TXA level', '(convenience)', '(convenience)', 'TXA level', '(convenience)', 'Blood draw 1 for TEG and other', 'Blood draw 2 for TEG and other', 'biomarker testing', 'biomarker testing', 'Figure 2: Flow diagram of blood draws for biomarker testing and TXA levels', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']['Protocol 036 (Nishijima, Kuppermann)', 'Page 21 of 74', 'children than similarly injured adults (24% VS. 9%). 16 Other studies have suggested', 'different thresholds for defining hyperfibrinolysis40 or other diagnostic measures such as', 'rotational thromboelastography or plasmin-antiplasmin complex levels. 42, 43 However', 'these diagnostic measures are limited by their availability in the US44 and their lack of', 'real time results. 43, 45 Given the ability for TEG testing to provide clinicians quickly', 'with data on fibrinolysis after trauma, TEG has been suggested as a means to directing', 'antifibrinolytic therapy.', '12, 39, 46', 'The objective of obtaining TEG testing (see TEG parameters in Figure 3) for the', 'pilot study is to demonstrate the feasibility of collecting TEG as part of study procedures.', 'Potential issues such as timing of blood collection and blood processing have not been', 'evaluated in a multicenter pediatric trauma trial. We will not analyze the association', 'with TEG results and outcomes in the pilot study due to the small number of subjects', 'enrolled, however we anticipate this analysis for the subsequent phase II/III trial.', 'Coagulation', 'Fibrinolysis', 'LY30', '30 min', 'alpha-angle', 'Maximum', 'amplitude', 'r-value', 'k-time', 'Figure 3: TEG parameters', 'Other biomarkers In addition to TEG, we will also measure other biomarkers that', 'directly or indirectly measure fibrinolysis. Examples of these plasma biomarkers include:', 'plasmin and d-dimer levels.', '3.4 Data Collection During Hospitalization', 'Data collection during the ED stay and hospitalization is summarized in the Schedule', 'of Evaluations (Figure 4 on page 23). After the initiation of treatment and recording of', 'TIC-TOC Trial Protocol Version 2.03', 'Protocol Version Date: October 24, 2018', 'The EMSC Pediatric Emergency Care Applied Research Network']\n\n###\n\n", "completion": "END"}